Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinoic acid receptors (RARs) and retinoid X receptors (RXRs) are a family of nuclear receptors that act as ligand-dependent transcription factors. They regulate gene expression in response to retinoids, such as retinoic acid (tretinoin) and other vitamin A derivatives. RARs and RXRs form heterodimers that bind to specific DNA sequences called retinoic acid response elements (RAREs) to control the transcription of target genes involved in cell growth, differentiation, and apoptosis.
Agonist of retinoic acid receptors (RARs) and/or retinoid X receptors (RXRs), leading to altered gene transcription.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoic acid receptors (RARs) and retinoid X receptors (RXRs) (RAR/RXR).